Differential diagnosis of amnestic dementia patients based on an FDG-PET signature of autopsy-confirmed LATE-NC
dc.contributor.author | Grothe, Michel J. | |
dc.contributor.author | Moscoso, Alexis | |
dc.contributor.author | Silva-Rodríguez, Jesús | |
dc.contributor.author | Lange, Catharina | |
dc.contributor.author | Nho, Kwangsik | |
dc.contributor.author | Saykin, Andrew J. | |
dc.contributor.author | Nelson, Peter T. | |
dc.contributor.author | Schöll, Michael | |
dc.contributor.author | Buchert, Ralph | |
dc.contributor.author | Teipel, Stefan | |
dc.contributor.author | Alzheimer’s Disease Neuroimaging Initiative | |
dc.contributor.department | Radiology and Imaging Sciences, School of Medicine | |
dc.date.accessioned | 2024-07-15T13:32:37Z | |
dc.date.available | 2024-07-15T13:32:37Z | |
dc.date.issued | 2023 | |
dc.description.abstract | Introduction: Limbic age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) is common in advanced age and can underlie a clinical presentation mimicking Alzheimer's disease (AD). We studied whether an autopsy-derived fluorodeoxyglucose positron emission tomography (FDG-PET) signature of LATE-NC provides clinical utility for differential diagnosis of amnestic dementia patients. Methods: Ante mortem FDG-PET patterns from autopsy-confirmed LATE-NC (N = 7) and AD (N = 23) patients were used to stratify an independent cohort of clinically diagnosed AD dementia patients (N = 242) based on individual FDG-PET profiles. Results: Autopsy-confirmed LATE-NC and AD groups showed markedly distinct temporo-limbic and temporo-parietal FDG-PET patterns, respectively. Clinically diagnosed AD dementia patients showing a LATE-NC-like FDG-PET pattern (N = 25, 10%) were significantly older, showed less abnormal AD biomarker levels, lower APOE ε4, and higher TMEM106B risk allele load. Clinically, they exhibited a more memory-predominant profile and a generally slower disease course. Discussion: An autopsy-derived temporo-limbic FDG-PET signature identifies older amnestic patients whose clinical, genetic, and molecular biomarker features are consistent with underlying LATE-NC. | |
dc.eprint.version | Author's manuscript | |
dc.identifier.citation | Grothe MJ, Moscoso A, Silva-Rodríguez J, et al. Differential diagnosis of amnestic dementia patients based on an FDG-PET signature of autopsy-confirmed LATE-NC. Alzheimers Dement. 2023;19(4):1234-1244. doi:10.1002/alz.12763 | |
dc.identifier.uri | https://hdl.handle.net/1805/42208 | |
dc.language.iso | en_US | |
dc.publisher | Wiley | |
dc.relation.isversionof | 10.1002/alz.12763 | |
dc.relation.journal | Alzheimer's & Dementia | |
dc.rights | Publisher Policy | |
dc.source | PMC | |
dc.subject | TDP-43 | |
dc.subject | TMEM106B | |
dc.subject | Amyloid | |
dc.subject | Apolipoprotein E | |
dc.subject | Autopsy | |
dc.subject | Fluorodeoxyglucose positron emission tomography | |
dc.subject | Hippocampal sclerosis | |
dc.subject | Limbic age-related TDP-43 encephalopathy | |
dc.subject | Tau | |
dc.title | Differential diagnosis of amnestic dementia patients based on an FDG-PET signature of autopsy-confirmed LATE-NC | |
dc.type | Article |